NADPH oxidase-IN-1 is an orally active NADPH oxidase (Nox) inhibitor associated with neuroinflammation; it crosses the blood-brain barrier and inhibits Nox2 and Nox4 with IC50 values of 1.9 μM and 2.47 μM, respectively; it suppresses pro-inflammatory cytokine production and LPS-mediated microglial migration, demonstrating in vivo efficacy.